If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2013.06-2015.06 Master of Bussiness, National Taiwan University
  • 1997.09-2002.01 PhD, Taipei Medical University
  • 1979.09-1986.06 MD, School of Medicine, Taipei Medical College

Experience

  • 2019.01- Vice superintendent, Taipei Medical University Hospital
  • 2013.09 Vice Dean, College of Medicine, Taipei Medical University
  • 2011.05 Chairman, School of Medicine, Taipei Medical University
  • 2009.08 Professor, School of Medicine, Taipei Medical University
  • 2008.06-2011.06 Vice superintendent, Taipei Medical University Hospital
  • 2007.02 Director, department of primary care medicine, Taipei Medical University Hospital

Awards

  • Consultant, Gastroenterolgical Society of Taiwan
  • Consultant, Digestive Endoscopic Society of Taiwan

Research Interests

  • Gastroenterology
  • GI tract cancer molecular medicine

Fingerprint Dive into the research topics where Shyr-Yi Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Apoptosis Medicine & Life Sciences
Dioscorea Medicine & Life Sciences
yams Agriculture & Biology
Neoplasms Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Colorectal Neoplasms Medicine & Life Sciences
Antioxidants Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2020

anti-EGFR×anti-FAP雙辨識特異性抗體結合包覆抗癌藥物Irinotecan標靶微脂體治療胰臟癌之研究(2/3)

Lin, S.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

臺北醫學大學自有貴重儀器共用服務計畫

Lin, S.

12/1/1812/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

林時宜-107研究計畫績效獎

Lin, S.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

開發帶有免疫提升佐劑之明膠微粒膠體劑型

Lin, S.

4/2/1911/2/19

Project: D - Other Project

anti-EGFR×anti-FAP雙辨識特異性抗體結合包覆抗癌藥物Irinotecan標靶微脂體治療胰臟癌之研究(1/3)

Lin, S.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 1991 2019

  • 2330 Citations
  • 28 h-Index
  • 111 Article
  • 2 Meeting Abstract
  • 1 Letter
  • 1 Review article

Alternative splicing in human cancer cells is modulated by the amiloride derivative 3,5-diamino-6-chloro-N-(N-(2,6-dichlorobenzoyl)carbamimidoyl)pyrazine-2-carboxide

Lee, C. C., Chang, W. H., Chang, Y. S., Yang, J. M., Chang, C. S., Hsu, K. C., Chen, Y. T., Liu, T. Y., Chen, Y. C., Lin, S. Y., Wu, Y. C. & Chang, J. G., Jan 1 2019, In : Molecular Oncology.

Research output: Contribution to journalArticle

Open Access
Pyrazines
Amiloride
Alternative Splicing
Neoplasms
RNA Sequence Analysis

Decellularized lymph node scaffolding as a carrier for dendritic cells to induce anti-tumor immunity

Lin, H. J., Wang, W., Huang, Y. Y., Liao, W. T., Lin, T. Y., Lin, S. Y. & Liu, D. Z., Nov 2019, In : Pharmaceutics. 11, 11, 553.

Research output: Contribution to journalArticle

Open Access
Dendritic Cells
Immunity
Lymph Nodes
Bone Marrow Cells
Ovalbumin

Deep Intronic Variant c.5999-277G>A of F8 Gene May Be a Hot-Spot Mutation for Mild Hemophilia A Patients Without Mutation in Exonic DNA

Chang, C-Y., Perng, C-L., Cheng, S-N., Hu, S-H., Wu, T-Y., Lin, S-Y. & Chen, Y-C., May 7 2019, In : European Journal of Haematology.

Research output: Contribution to journalArticle

Hemophilia A
Mutation
DNA
Exons
Genes

Simply Mixing Poly Protein G with Detection Antibodies Enhances the Detection Limit and Sensitivity of Immunoassays

Chen, Y. J., Chen, M., Cheng, T. L., Roffler, S. R., Lin, S. Y., Hsu, H. L., Wang, C. H., Chen, C. Y., Kao, A. P., Cheng, J. J. & Chuang, K. H., Jan 1 2019, In : Analytical Chemistry.

Research output: Contribution to journalArticle

Antibodies
Proteins
Flow cytometry
Molecules
Interferons
Dioscorea
Glucose Intolerance
dipeptides
Dipeptides
yams